Why You Shouldn't Swap Enbrel for Erelzi Just Yet

Swap Enbrel for Erelzi? Erelzi, the biosimilar to Enbrel, has been approved by the FDA. Biosimilars are supposed to be equivalent and more affordable. Are we sure about that? READ NOW  READ THESE NEXT Inflectra, Biosimilar to Remicade, Held Up by Patent Issues MORE Are Biosimilars Like Generics? MORE Should Everyone With Arthritis Be Prescribed a Biologic Drug? MORE AN ABOUT.COM BRAND You are receiving this newsletter because you subscribed to the Real Life with Arthritis newsletter. If you wish to unsubscribe, please click here 1500 Broadway, 6th Floor, New York, NY, 10036 © 2016 Verywell.com - All rights reserved. Privacy Policy.